2Takata K, Kubota S, Fukata S, et al. Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily[J]. Thyroid, 2009, 19(6): 559-563.
3Huang YP, Lee NY, Chang CM, et al. Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever,rash,or neutropenia: a retrospective chart review[J]. Clin Ther, 2009, 31(9): 1977-1986.
6Hung YP, Lee NY, Chang CM, et al. Tolerability of teieoplanin in 117 hospitalized adults with previous vancomyein-induced fever, rash, or neutropenia : a retrospective chart review[J]. Clin Ther, 2009, 31 (9) : 1977- 1996.
7Pai MP, Mercier RC, Koster SA. Epidemiology of vancomycin-induced neutropenia in patients receiving home intravenous infusion therapy [ J ]. Ann Pharmacother, 2006, 40(2) : 224-228.
8Hassaballa H, Mallick N, Orlowski J. Vancomycin anaphylaxis in a patient with vancomycin-induced red man syndrome[J]. Am J Ther, 2000, 7(5) : 319-320.
9Sahai J, Healy D P, Shelton M J, et al. Comparison of vancomycin- and teicoplanin- induced histamine release and " red man syndrome" [ J ]. Antimicrob Agents Chemother, 1990, 34(5) : 765-769.
10Sera N, Ashizawa K, Ando T, et al. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves disease. Thyroid, 2000, 10: 595-599.
